Combination of bevacizumab (B) plus immunotherapy, with interleukin-2 (IL-2) and interferon-α (IFN-α) plus chemotherapy (BIC) in patients with metastatic renal cell cancer (mRCC): Dose-finding phase ...
Patients with an abnormal D-dimer level one month following the discontinuation of anticoagulation therapy had a significant incidence of recurrent venous thromboembolism, and resuming anticoagulation ...
Biomarkers that reliably identify or even predict disease manifestations in systemic lupus erythematosus (SLE) are needed. In a recent issue of the Clinical Journal of the American Society of ...
This webinar will discuss the influence of anticoagulants on laboratory testing results for thrombophilia and appropriate testing situations for patients suspected of thromboembolism. In addition, we ...
Bologna 8 April 2022 - Patients who have suffered from a first episode of unprovoked venous thromboembolism (VTE) have an eight times higher risk of recurrence if they stop treatment after repeated ...
Anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast cancer: A meta-analysis. This is an ASCO Meeting Abstract from the 2013 ASCO Annual ...
The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still spreading across many parts of the world, and clinicians are working on recognizing biomarkers ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. More than one-quarter of patients with COVID-19 had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results